Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Nordic 8 - A Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
- Status
- COMPLETED
- Phase
- PHASE2
A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib + mFOLFOX for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2